Vaccines/Immunizations
The following articles contain information and resources to help families learn more about vaccines, their effectiveness, and their safety. To learn more, visit All About the AAP Immunization Schedule.
All of the Vaccine Information Sheets are listed within the first accordion tab: Vaccine Information.
Vaccine Information
Influenza Vaccine
Find information about our flu clinics, general flu vaccine information and more. Read more...
COVID Vaccine Information
We will make every attempt to keep this page up to date, but there is a lot of unknown with the future of vaccination recommendations and the situation is very fluid.
Pharmacies are offering COVID vaccines to those over 12 years of age with high risk conditions (see below). Some may be offering COVID vaccines to younger children - check with your pharmacy.
We have started to receive COVID vaccines for children under 12 years of age. We are getting small amounts at a time, so if they are available we can give them, but we will not offer mass vaccination clinics.
The health department is also able to give the COVID19 vaccine. Johnson County KS Health Department information can be found here or you can search for your county's health department.
If you are interested in your 6 month through 11 year old getting vaccinated, call to see if we have the right dose for your child's age and insurance.
Those who are getting VFC vaccines (Medicaid, Native Americans, or uninsured) must meet the requirements as stated per the CDC for risk factors. We believe that private insurance companies are not going to track risk factors. We believe that insurance will cover these vaccines, but may require parents to sign an agreement that they will cover costs if insurance does not cover it because we cannot afford to cover this cost.
What are the FDA-approved COVID-19 vaccines for 2025/26?
- Moderna for those 6 months and up who have at least 1 high risk health condition*
- Pfizer for those 5 years and up with a high risk condition*
- Novavax is approved for those 12 years and up with high risk conditions*
- No high risk condition is required for those 65 years and up
*High risk conditions include, but are not limited to the following: those most commonly seen in our clinics are in bold:**
- obesity (Body Mass Index (BMI) at or above the 95th percentile for children)
- lack of physical exercise
- diabetes (both types 1 and 2)
- cardiac, lung (including asthma and cystic fibrosis), liver, kidney, hematologic, and neurologic disorders
- ADHD
- mood disorders, including depression
- medical complexity
- smoker (current or past is included, but vaping is not specified)
Also, shared decision making is an option:
- advice from your healthcare provider (this is the shared decision-making option - yes, we want our patients to have this vaccine, so if your pharmacy asks you, we said to get it!)
There are no FDA-approved COVID-19 vaccines for “healthy” infants and teens, despite the known higher risk of children under 2 years of age and the proven safety and efficacy of these vaccines. The AAP and other medical organizations are advocating for continued use of these vaccines to protect all children and adults.
Pregnancy is listed as a high risk condition, yet there is no vaccine currently approved for use during pregancy. The CDC list itself states, “Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy was associated with a reduced risk of hospitalization for COVID-19, including for critical illness, among infants younger than 6 months of age,” but the FDA has failed to approve a COVID19 vaccine for use during pregnancy, so it is unclear if infants will be able to be protected during pregnancy.
AAP Recommendations
The American Academy of Pediatrics (AAP) and other professional organizations have released their recommendations that differ from the FDA this year.
The AAP recommends that:
- all children 6 months to 2 years of age get vaccinated against COVID-19
- all children who have not yet been vaccinated against COVID get vaccinated
- all high-risk children and children living with high-risk people should be vaccinated
- any child of a parent who desires vaccination should be able to be vaccinated
Will insurance cover COVID-19 vaccines?
Insurers are required to cover vaccines listed in the CDC immunization schedules, including shared clinical decision-making recommendations, which may qualify anyone for COVID vaccination.
This year insurers may consider the recommendations of medical professional groups, including the American Academy of Pediatrics (AAP), American Medical Association (AMA), and American College of Obstetrics and Gynecology (ACOG) to best protect their insured and to decrease overall hospitalization rates.
Do we recommend vaccination?
Yes, we recommend the vaccine for all who are eligible.
We strongly recommend COVID-19 vaccination annually for all eligible patients and their families to help prevent serious acute and chronic problems that can arise from SARS-CoV2 infections, even in young, healthy people.
Are the vaccines safe?
- The side effects have been similar to other routine vaccines- sore arm, redness, fatigue, fever, chills, headache, myalgia, and arthralgia. The side effects are temporary and mostly mild or moderate and much less significant than effects of infections with the virus.
- Anaphylaxis has been observed following receipt of COVID-19 mRNA vaccines, but this has been rare.
- Extremely rare cases of myocarditis or pericarditis have been reported – most often in males between 12-39 years of age, but it is important to note that infections with SARS-CoV-2 cause higher rates and severity of myocarditis than the vaccine.
- Additional information on common side effects and rare adverse reactions can be found here:
- COVID-19 Vaccine Information Sheet (VIS
For updates:
In addition to our updates, the AAP has a page of COVID-related news that you can check to see if there are any changes. Visit it on https://publications.aap.org/aapnews/news/1362/COVID-19-pandemic.
For information on Long COVID:
- Visit our COVID and Long-covid page
What can you do to help get your family protected?
Be an advocate! Call or write to your representatives to let them know you want the choice to have COVID vaccines for your family.
Find your reps: usa.gov/elected-officials
What if you're pregant or breastfeeding?
This is from https://www.cdc.gov/covid/vaccines/pregnant-or-breastfeeding.html but may change based on the orange box at the top:



Find information about long COVID
RSV Prevention
RSV Prevention - 2025/26 Season
We will be offering Beyfortus to eligible patients at their regularly scheduled visits and as scheduled nurse visits for those eligible without an upcoming appointment starting October 1st.
Medical stuff to know about RSV and the preventions available
- RSV is one of the most common causes of childhood respiratory illness and results in annual outbreaks of respiratory illnesses in all age groups.
- Each year in the US RSV leads to approximately:
◾️2.1 million outpatient medical visits in children under 5 years
◾️58,000-80,000 hospitalizations in kids under 5 years
◾️60,000-160,000 hospitalizations in adults over 65 years
◾️6,000-10,000 deaths in adults over 65 years
◾️100–300 deaths in children under 5 years - You can learn how to manage RSV infections at home and when to seek medical attention here.
- Beyfortus (nirsevimab) and Synagis (palivizumab) are both monoclonal antibody injections that give passive immunity. They are not typical immunizations that help the immune system develop ways to fight infection. They’re given to prevent serious respiratory illness from RSV in young children. Beyfortus protects for 5 months (a full RSV season) whereas Synagis only lasts 1 month (requiring monthly injections). Synagis will no longer be available as of December 31, 2025.
- Both Beyfortus and Synagis can be given with other vaccines.
- Beyfortus is recommended for all newborns and infants up to 8 months old*, starting at birth, during the RSV season. Some children up to 19 months old who are at higher risk of severe RSV can also get this vaccine.
* An RSV vaccine is also available to give during pregnancy to protect the baby. If a baby got the benefit of this vaccine more than 2 weeks prior to delivery, no further RSV protection is needed unless the baby is in a high risk group.
Infants 8-19 months can get Beyfortus if:
- they have chronic lung disease from being born premature and are requiring medical therapy for their lung disease
- they are severely immunocompromised
- have cystic fibrosis with severel lung disease or weight for length less than the 10th percentile
- American Indian and Alaska Native children
- RSV (Respiratory Syncytial Virus) Preventive Antibody Immunization Information Statement
Insurance issues
- Insurance covered Beyfortis very well overall during the 2024/25 season and we expect that it will continue to be covered but there is no guarantee with any individual private insurance plan.
- VFC will cover Beyfortus for all eligible Medicaid patients as well as Native American and Alaskan children.
- Parents must sign an ABN (Advance Beneficiary Notice) if they want their child to be protected with Beyfortus until the insurance issues are clarified and we can rely on insurance payments. This ABN will state that parents will pay if insurance does not.
- When asking insurance if they cover Beyfortus, the CPT codes we will use are 90380 (5kg or less) or 90381 (more than 5kg).
- Newborns are not eligible until they are able to show proof of insurance. This is because it is not uncommon for the eligibility of the Vaccine for Children (VFC) program to change from what we are originally told. We could be charged significant fines or lose our ability to participate in the VFC program if we inadvertently give an ineligilbe child a VFC product or a private stock vaccine to a patient eligible for VFC. We cannot take this risk.
Scheduling
- Beyfortis is approved for use starting October 1st through March 31st to cover the typical RSV season.
- When we have Beyfortus in stock, any eligible infant in the office will be offered Beyfortus at the time of their visit.
Approximate timing of nirsevimab
(based on availability, catch up may be needed later in the season)





Vaccine Policy
At Pediatric Partners, an Affiliate of Children's Mercy, our main concern is the health of your child. We strongly believe that immunizations play an important role in maintaining your child’s health from infancy to adulthood. Read more...
Standard Vaccine Schedule at Pediatric Partners
This page lists the vaccines we typically give at various ages, as well as links to the Vaccine Information Sheets for each vaccine. The AAP recommended schedule is also shared. Read more...
Kansas Immunization Requirements
Current information on immunization requirements for the state of Kansas. Read more...
Missouri Vaccine Requirements
Current Missouri vaccine requirements. Read more...
What if my insurance doesn't cover immunizations?
If your insurance does not cover immunizations, there are options. Read more...
Care After Immunizations
Immunizations are very important to keep children healthy. Please review the Vaccine Information Sheets for possible side effects that your child might have. This information tells you what to do for minor side effects. Read more...
Recommended Immunization Schedule
Birth
Hep B
RSV
1 month
Hep B
2 months
DTaP
Hep B
HIB
IPV
PCV
Rotavirus
4 months
DTaP
Hep B
HIB
IPV
PCV
Rotavirus
6 months
DTaP
Hep B
HIB
IPV
PCV
Rotavirus
6 months +
Influenza and COVID-19 Vaccination
9 months
Hep B
12 months
Hep A
MMR
PCV
Varicella
15 months
DTaP
HIB
18 months
Hep A
There is a minimum of 6 months between doses.
4 years
DTaP
IPV
MMR
Varicella
5-9 years
IPV
At least one dose is required after the 4th birthday, so some children may require more than 4 doses if doses were given earlier.
10+ years
Meningococcal (Men B)
If local outbreak; absent or damaged spleen; complement deficiency
11 years
HPV (Gardasil)
Meningococcal (ACWY)
Tdap
12 years
HPV (Gardasil)
2nd shot: 6-12 months after the first shot
15 years
HPV (Gardasil)
if the series is started at 15 yrs or older: 3 doses are given- 2nd dose 1-2 months after 1st and 3rd dose 6 months after the first dose
16 years
Meningococcal ACWY
16+ years
TdaP
A tetanus booster is recommended every 10 years and can be given as a Tdap or Td. We recommend the Tdap. A Tdap is also recommended with each pregnancy.
16-18 years
Meningococcal (Men B)
This vaccine is required for some colleges and has a Category B recommendation - it can be given but is not given the stronger Category A recommendation. Talk to your physician to discuss when it is indicated.
Immunization Schedule Text Only v1.0 updated 8/7/2025
More Immunization Articles
Customized from Immunization Handouts and Articles v0.1 6/27/2025

